JPMorgan Chase & Co. initiated coverage on shares of GlaxoSmithKline (LON:GSK) in a report issued on Tuesday, MarketBeat.com reports. The brokerage set a “neutral” rating and a GBX 1,700 ($22.21) price target on the stock. JPMorgan Chase & Co.‘s price objective points to a potential upside of 2.43% from the company’s current price.
A number of other analysts also recently issued reports on the company. Goldman Sachs Group set a GBX 1,900 ($24.83) target price on GlaxoSmithKline and gave the stock a “buy” rating in a research note on Monday, July 22nd. HSBC set a GBX 1,942 ($25.38) target price on GlaxoSmithKline and gave the stock a “buy” rating in a research note on Tuesday, July 16th. Jefferies Financial Group reaffirmed a “buy” rating on shares of GlaxoSmithKline in a research note on Friday, May 24th. Liberum Capital reissued a “hold” rating on shares of GlaxoSmithKline in a research report on Tuesday, July 2nd. Finally, Shore Capital reissued a “hold” rating on shares of GlaxoSmithKline in a research report on Wednesday, July 10th. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of GBX 1,638.06 ($21.40).
Shares of GSK opened at GBX 1,659.60 ($21.69) on Tuesday. GlaxoSmithKline has a 52-week low of GBX 1,408.80 ($18.41) and a 52-week high of GBX 1,749.40 ($22.86). The firm has a market cap of $82.78 billion and a P/E ratio of 18.69. The business has a fifty day moving average of GBX 1,651.25. The company has a quick ratio of 0.44, a current ratio of 0.71 and a debt-to-equity ratio of 1,127.74.
GlaxoSmithKline Company Profile
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare.
Further Reading: What is a conference call?
Receive News & Ratings for GlaxoSmithKline Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline and related companies with MarketBeat.com's FREE daily email newsletter.